
From the SRF Regional Journal Basel Podcast Interview of CordenPharma CEO Dr. Michael Quirmbach on 05.03.2025 – An aerial sketch shows the new production site in Schweizerhalle, which is scheduled to go into operation in 2028
SRF Swiss Radio & Television Regional Journal Basel Podcast: Basel company invests 500 million Euros in Muttenz
CordenPharma, headquartered in Basel, produces Active Pharmaceutical Ingredients for medications, including the booming weight-loss drugs market. Therefore, the pharmaceutical supplier is now building a new production facility in Schweizerzerhalle, outside Basel, and creating around 300 new jobs.
Additional Local Basel Newspaper coverage on 5 March, 2025
Want to find out more?
Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.